<<Disclaimer: Verify this information before applying it to your situation.>>

Chaitan Khosla is now heading up Alvine Pharmaceuticals, a new company 
formed to commercialize the gluten-detoxifying protease developed by the 
Celiac Sprue Research Foundation in Stanford.  $21 million in venture 
capital has been raised to fund the startup.

< http://biz.yahoo.com/prnews/060912/sftu130.html >

* * *

* All posts for product information must include the applicable country *
Archives are at: Http://Listserv.icors.org/SCRIPTS/WA-ICORS.EXE?LIST=CELIAC